Study on Post-Surgery Chemotherapy Treatments for Appendix, Colon, or Rectum Cancer with Peritoneal Spread

Sponsor: Memorial Sloan Kettering Cancer Center

Sponsor score: 60

ClinicalTrials ID:NCT01815359

This clinical trial is comparing two types of chemotherapy treatments given after surgery to remove cancer from the appendix, colon, or rectum that has spread to the lining of the abdomen. The study aims to understand the effects of these treatments on patients and their cancer.

Patient Parameters

Program Overview

This study is the first to compare two chemotherapy methods, EPIC and HIPEC, used after surgery to remove cancer from the appendix, colon, or rectum that has spread to the abdominal lining. The goal is to see how these treatments affect patients and their cancer, both positively and negatively.

Eligibility Criteria

Inclusion Criteria

  • Must be 18 years or older.
  • Diagnosed with cancer of the appendix or colon/rectum that has spread to the abdominal lining.
  • Planning to have surgery to remove all visible cancer in the abdomen.
  • In good general health, able to perform daily activities with minimal restrictions.
  • Have adequate blood cell counts and organ function based on specific medical tests.
  • Women of childbearing age must test negative for pregnancy and agree to use effective birth control during the study.
  • Men must agree to use reliable birth control methods during the study.
  • Must provide written consent to participate in the study.
  • If previously diagnosed with endometrial cancer, must have had a low-stage, non-aggressive form.

Exclusion Criteria

  • Have had chemotherapy directly into the abdomen before.
  • Have certain types of tumors with low potential to spread.
  • Have had other cancers unless they were treated and inactive for over three years.
  • Cancer has spread beyond the abdomen or lymph nodes.
  • Pregnant or breastfeeding women.
  • Have medical conditions that prevent understanding or participating in the study.
  • Have active heart disease or uncontrolled high blood pressure.
  • Have severe lung disease or heart failure.
  • Have had a stroke or other severe medical issues that limit participation.
  • Allergic to specific chemotherapy drugs used in the study.
  • Have extensive scar tissue in the abdomen that prevents treatment.
  • Taking medications that cannot be safely stopped for the study.
  • Have a life expectancy of less than 12 weeks.

Locations

FACILITYZIPCITYSTATE
University of MiamiMiamiFlorida
Washington University School of Medicine63110St LouisMissouri
Memorial Sloan Kettering Basking Ridge (Consent and Follow up)07920Basking RidgeNew Jersey
Memorial Sloan Kettering Monmouth (Consent and Follow up)07748MiddletownNew Jersey
Memorial Sloan Kettering Bergen (Consent and Follow up)07645MontvaleNew Jersey
Memorial Sloan Kettering Commack (Consent and Follow up)11725CommackNew York
Memorial Sloan Kettering Westchester (Consent and Follow up)10604HarrisonNew York
Memorial Sloan Kettering Cancer Center10065New YorkNew York
Memorial Sloan Kettering Nassau (Consent and Follow up)11553UniondaleNew York

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.